On March 15, 2022 Philogen reported its attendance at the AACR (Free AACR Whitepaper) Annual Meeting on April 8-13, 2022 (Press release, Philogen, MAR 15, 2022, View Source [SID1234610106]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Aureliano Zana, 3rd year PhD student at Philogen, is presenting an ePoster entitled "Fibroblast Activation Protein triggers release of drug payload from non-internalizing small molecule-drug conjugates in solid tumors"

Andrea Galbiati, Senior Scientist at Philogen, is presenting an ePoster entitled "A novel dimeric small molecule-radio conjugate targeting fibroblast activation protein with high and prolonged tumor uptake"

Lisa Nadal, Junior Project Manager at Philogen, is presenting an ePoster entitled "A novel IL12-based immunocytokine targeting fibroblast activation protein (FAP) for the treatment of cancer"